世界のANCA関連血管炎薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV02431)
◆英語タイトル:Global Anca Vasculitis Drug Market Insights and Forecast to 2026
◆商品コード:QYR20NV02431
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはANCA関連血管炎薬の世界市場について調査・分析した資料です。種類別(ベリムマブ、CCX-1378、CCX-168、ダラザチド、その他)の市場規模、用途別(病院、診療所、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ANCA関連血管炎薬の競争状況、市場シェア
・世界のANCA関連血管炎薬市場:種類別市場規模 2015年-2020年(ベリムマブ、CCX-1378、CCX-168、ダラザチド、その他)
・世界のANCA関連血管炎薬市場:種類別市場規模予測 2021年-2026年(ベリムマブ、CCX-1378、CCX-168、ダラザチド、その他)
・世界のANCA関連血管炎薬市場:用途別市場規模 2015年-2020年(病院、診療所、その他)
・世界のANCA関連血管炎薬市場:用途別市場規模予測 2021年-2026年(病院、診療所、その他)
・北米のANCA関連血管炎薬市場分析:米国、カナダ
・ヨーロッパのANCA関連血管炎薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのANCA関連血管炎薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のANCA関連血管炎薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのANCA関連血管炎薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):ChemoCentryx, Inc.、GlaxoSmithKline plc、Kineta, Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Anca Vasculitis Drug Market
The global Anca Vasculitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Anca Vasculitis Drug Scope and Market Size
Anca Vasculitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anca Vasculitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Anca Vasculitis Drug market is segmented into
Belimumab
CCX-1378
CCX-168
Dalazatide
Others

Segment by Application, the Anca Vasculitis Drug market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Anca Vasculitis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anca Vasculitis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anca Vasculitis Drug Market Share Analysis
Anca Vasculitis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anca Vasculitis Drug business, the date to enter into the Anca Vasculitis Drug market, Anca Vasculitis Drug product introduction, recent developments, etc.

The major vendors covered:
ChemoCentryx, Inc.
GlaxoSmithKline plc
Kineta, Inc.

【レポートの目次】

1 Study Coverage
1.1 Anca Vasculitis Drug Product Introduction
1.2 Market Segments
1.3 Key Anca Vasculitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anca Vasculitis Drug Market Size Growth Rate by Type
1.4.2 Belimumab
1.4.3 CCX-1378
1.4.4 CCX-168
1.4.5 Dalazatide
1.4.6 Others
1.5 Market by Application
1.5.1 Global Anca Vasculitis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Anca Vasculitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Anca Vasculitis Drug Revenue 2015-2026
2.1.2 Global Anca Vasculitis Drug Sales 2015-2026
2.2 Global Anca Vasculitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anca Vasculitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anca Vasculitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Anca Vasculitis Drug Competitor Landscape by Players
3.1 Anca Vasculitis Drug Sales by Manufacturers
3.1.1 Anca Vasculitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Anca Vasculitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Anca Vasculitis Drug Revenue by Manufacturers
3.2.1 Anca Vasculitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Anca Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anca Vasculitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anca Vasculitis Drug Revenue in 2019
3.2.5 Global Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anca Vasculitis Drug Price by Manufacturers
3.4 Anca Vasculitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Anca Vasculitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anca Vasculitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Anca Vasculitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Anca Vasculitis Drug Market Size by Type (2015-2020)
4.1.1 Global Anca Vasculitis Drug Sales by Type (2015-2020)
4.1.2 Global Anca Vasculitis Drug Revenue by Type (2015-2020)
4.1.3 Anca Vasculitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anca Vasculitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Anca Vasculitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Anca Vasculitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Anca Vasculitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anca Vasculitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Anca Vasculitis Drug Market Size by Application (2015-2020)
5.1.1 Global Anca Vasculitis Drug Sales by Application (2015-2020)
5.1.2 Global Anca Vasculitis Drug Revenue by Application (2015-2020)
5.1.3 Anca Vasculitis Drug Price by Application (2015-2020)
5.2 Anca Vasculitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Anca Vasculitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Anca Vasculitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Anca Vasculitis Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anca Vasculitis Drug by Country
6.1.1 North America Anca Vasculitis Drug Sales by Country
6.1.2 North America Anca Vasculitis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anca Vasculitis Drug Market Facts & Figures by Type
6.3 North America Anca Vasculitis Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Anca Vasculitis Drug by Country
7.1.1 Europe Anca Vasculitis Drug Sales by Country
7.1.2 Europe Anca Vasculitis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anca Vasculitis Drug Market Facts & Figures by Type
7.3 Europe Anca Vasculitis Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Anca Vasculitis Drug by Region
8.1.1 Asia Pacific Anca Vasculitis Drug Sales by Region
8.1.2 Asia Pacific Anca Vasculitis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anca Vasculitis Drug Market Facts & Figures by Type
8.3 Asia Pacific Anca Vasculitis Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Anca Vasculitis Drug by Country
9.1.1 Latin America Anca Vasculitis Drug Sales by Country
9.1.2 Latin America Anca Vasculitis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anca Vasculitis Drug Market Facts & Figures by Type
9.3 Central & South America Anca Vasculitis Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Anca Vasculitis Drug by Country
10.1.1 Middle East and Africa Anca Vasculitis Drug Sales by Country
10.1.2 Middle East and Africa Anca Vasculitis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anca Vasculitis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Anca Vasculitis Drug Market Facts & Figures by Application

11 Company Profiles
11.1 ChemoCentryx, Inc.
11.1.1 ChemoCentryx, Inc. Corporation Information
11.1.2 ChemoCentryx, Inc. Description and Business Overview
11.1.3 ChemoCentryx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Products Offered
11.1.5 ChemoCentryx, Inc. Related Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Corporation Information
11.2.2 GlaxoSmithKline plc Description and Business Overview
11.2.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline plc Anca Vasculitis Drug Products Offered
11.2.5 GlaxoSmithKline plc Related Developments
11.3 Kineta, Inc.
11.3.1 Kineta, Inc. Corporation Information
11.3.2 Kineta, Inc. Description and Business Overview
11.3.3 Kineta, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Kineta, Inc. Anca Vasculitis Drug Products Offered
11.3.5 Kineta, Inc. Related Developments
11.1 ChemoCentryx, Inc.
11.1.1 ChemoCentryx, Inc. Corporation Information
11.1.2 ChemoCentryx, Inc. Description and Business Overview
11.1.3 ChemoCentryx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Products Offered
11.1.5 ChemoCentryx, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anca Vasculitis Drug Market Estimates and Projections by Region
12.1.1 Global Anca Vasculitis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Anca Vasculitis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.2.2 North America: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anca Vasculitis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anca Vasculitis Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anca Vasculitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

ChemoCentryx, Inc.、GlaxoSmithKline plc、Kineta, Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のANCA関連血管炎薬市場2026:インサイト・予測(Global Anca Vasculitis Drug Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。